ZoneOne Pharma Overview

  • Founded
  • 2011
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $994K
Latest Deal Amount
  • Investors
  • 2

ZoneOne Pharma General Information


Developer of nano-scale therapeutics. The company develops liposomal chelator therapeutics and contract formulation of liposome drugs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Primary Office
  • QB3 Byers Hall, 1700 4th Street
  • Suite 214
  • San Francisco, CA 94158
  • United States
+1 (415) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ZoneOne Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-May-2015 $994K Completed Startup
1. Accelerator/Incubator Completed Startup
To view ZoneOne Pharma’s complete valuation and funding history, request access »

ZoneOne Pharma Executive Team (3)

Name Title Board Seat Contact Info
Charles Noble Ph.D President & Founding Scientist
Peter Working Ph.D Co-Founder & Director of Regulatory Affairs
Mark Hayes Ph.D Co-Founder & Senior Scientist
To view ZoneOne Pharma’s complete executive team members history, request access »

ZoneOne Pharma Board Members (1)

Name Representing Role Since
J.P. Michael Motion Ph.D ZoneOne Pharma Board Member 000 0000
To view ZoneOne Pharma’s complete board members history, request access »

ZoneOne Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0
To view ZoneOne Pharma’s complete investors history, request access »